1. Mortality from asthma: a new epidemic in New Zealand;Jackson, R.T.; Beaglehole, R.; Rea, H.H.; Sutherland, D.C.;Br Med J,1982
2. A comparison of the cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol and isoprenaline;Crane, J.; Burgess, C.; Beasley, R.;Thorax,1989
3. Resistance to beta-adrenoceptor stimulants (a possible explanation for the rise in asthma deaths);Conolly, M.E.; Davies, D.S.; Dollery, C.T.; George, C.F.;Br J Pharmacol,1971
4. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline;Vathenen, A.S.; Knox, A.J.; Higgins, B.G.; Britton, JR, Tattersfield; A.E.;Lancet,1988
5. Patients at risk for dying ofasthma: New Zealand experience;Sears, M.R.;J Allergy Clin Immunol,1987